Related Experiment Video

Updated: Jun 17, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

20.9K

Breaking barriers: noncanonical inflammasome executes blood-brain barrier disruption

Martin Dichgans1,2,3,4, Jonas J Neher5,6,7, Yaw Asare8

  • 1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilian-University (LMU), Munich, Germany. martin.dichgans@med.uni-muenchen.de.

Signal Transduction and Targeted Therapy
|August 7, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.7K

Related Experiment Videos

Last Updated: Jun 17, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

20.9K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.7K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.1K
Overview
47.1K
Inflammation01:38

Inflammation

53.3K
Overview
53.3K

Articles linked to this work by shared authors, journal, and citation graph.

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026

Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology.

Journal of neuroinflammation·2026

Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke.

Cardiovascular research·2026

Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis.

Brain : a journal of neurology·2026

IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity.

Science advances·2026

Atomic structures of medin and Aβ fibrils reveal polymorphic remodeling in mixed amyloid systems.

Nature communications·2026

Intratumoral Mycobacterium abscessus promotes cytidine deaminase mutagenesis in non-small cell lung cancer.

Signal transduction and targeted therapy·2026

Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation.

Signal transduction and targeted therapy·2026

First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial.

Signal transduction and targeted therapy·2026

Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases.

Signal transduction and targeted therapy·2026

PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation.

Signal transduction and targeted therapy·2026

Three-year adjuvant treatment of icotinib in stage II-IIIA EGFR-mutated lung adenocarcinoma (ICWIP): a randomized, double-blind, placebo-controlled phase 3 trial.

Signal transduction and targeted therapy·2026

Species-specific iNOS expression distinguishes epithelial and myeloid IFNγ responses in tuberculosis.

American journal of respiratory cell and molecular biology·2026

Evaluating an anti-idiotype derived germline-targeting immunogen designed to elicit VRC01-class precursors in human antibody transgenic mice.

mSphere·2026

Unraveling the drug resistance web in IBD: The gut microbiota-immunity-epigenetics axis.

Gut microbes·2026

Immunometabolic Control of Neutrophil Plasticity in Tuberculosis.

Cell biology international·2026

Probable Coxsackievirus Infection in an Immunocompetent Adult With Genital and Oral Ulcerations Mimicking Herpes Simplex Virus Infection and Behçet's Disease.

Cureus·2026

Intestinal stem cells as innate immune sentinels: coupling environmental sensing to epithelial adaptation.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us